Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.38

-9.0%

Nov 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Art Bechhoefer who wrote (51710)	4/6/2021 4:54:03 PM
From: A.J. Mullen	Read Replies (1) of 52153

That's additional information I would have preferred sooner. It seems like a slip that should have been caught sooner, but better late than being caught by the FDA. Conference Call and Webcast Details FibroGen will host a conference call and webcast today, April 6, 2021, at 5:00 pm Eastern Time (2:00 p.m. Pacific Time) to discuss this matter. Interested parties may access a live audio webcast of the conference call via the FibroGen website at fibrogen.gcs-web.com. It is recommended that listeners access the website 15 minutes prior to the start of the call to download and install any necessary audio software. Dial-In Information Live (U.S./Canada): (877) 658-9081 Live (International): (602) 563-8732 Confirmation number: 5297733 A replay of the webcast and investor presentation will be available shortly after the call for a period of 30 days. To access the replay, please dial (855) 859-2056 (domestic) or (404) 537-3406 (international), and use passcode 52977 https://finance.yahoo.com/news/fibrogen-provides-additional-information-roxadustat-200100413.html

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next